WO2005085861A3 - Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer - Google Patents
Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer Download PDFInfo
- Publication number
- WO2005085861A3 WO2005085861A3 PCT/EP2005/050897 EP2005050897W WO2005085861A3 WO 2005085861 A3 WO2005085861 A3 WO 2005085861A3 EP 2005050897 W EP2005050897 W EP 2005050897W WO 2005085861 A3 WO2005085861 A3 WO 2005085861A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- disorders
- liver
- encoded polypeptides
- liver disorders
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04100857.4 | 2004-03-03 | ||
EP04100858.2 | 2004-03-03 | ||
EP04100857 | 2004-03-03 | ||
EP04100858 | 2004-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005085861A2 WO2005085861A2 (en) | 2005-09-15 |
WO2005085861A3 true WO2005085861A3 (en) | 2006-02-02 |
Family
ID=34921312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/050897 WO2005085861A2 (en) | 2004-03-03 | 2005-03-01 | Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005085861A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6913697B2 (en) | 2001-02-14 | 2005-07-05 | Science & Technology Corporation @ Unm | Nanostructured separation and analysis devices for biological membranes |
US7842291B1 (en) * | 2006-05-22 | 2010-11-30 | Celera Corporation | Methods and compositions for diagnosing and treating diseases |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
WO2007147074A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Use of highly parallel snp genotyping for fetal diagnosis |
EP2201562B1 (en) | 2007-09-11 | 2018-04-25 | University of Massachusetts | Insulin-like growth factor binding protein 7 for treatment of cancer |
EP2586865B1 (en) * | 2010-06-24 | 2018-03-21 | Genomictree, Inc. | Recombinant vector for suppressing proliferation of human papillomavirus cell including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papillomavirus |
JP2014503222A (en) | 2011-01-18 | 2014-02-13 | エバリスト ジェノミックス, インコーポレイテッド | Prognostic signs of colorectal cancer recurrence |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1281898A (en) * | 2000-06-27 | 2001-01-31 | 国家人类基因组南方研究中心 | Human zinc finger protein isomer and its code sequence |
WO2001059063A2 (en) * | 2000-01-31 | 2001-08-16 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2002029103A2 (en) * | 2000-10-02 | 2002-04-11 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
WO2002070539A2 (en) * | 2001-03-05 | 2002-09-12 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
US20020155513A1 (en) * | 1999-04-13 | 2002-10-24 | Hsu Daniel K. | Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma |
WO2002086076A2 (en) * | 2001-04-19 | 2002-10-31 | Bristol-Myers Squibb Company | Polynucleotides and polypeptides associated with the nf-kb pathway |
WO2003100429A2 (en) * | 2002-05-23 | 2003-12-04 | Sunnybrook And Women's College Health Sciences Centre | Diagnosis of hepatocellular carcinoma |
-
2005
- 2005-03-01 WO PCT/EP2005/050897 patent/WO2005085861A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020155513A1 (en) * | 1999-04-13 | 2002-10-24 | Hsu Daniel K. | Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma |
WO2001059063A2 (en) * | 2000-01-31 | 2001-08-16 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
CN1281898A (en) * | 2000-06-27 | 2001-01-31 | 国家人类基因组南方研究中心 | Human zinc finger protein isomer and its code sequence |
WO2002029103A2 (en) * | 2000-10-02 | 2002-04-11 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
WO2002070539A2 (en) * | 2001-03-05 | 2002-09-12 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
WO2002086076A2 (en) * | 2001-04-19 | 2002-10-31 | Bristol-Myers Squibb Company | Polynucleotides and polypeptides associated with the nf-kb pathway |
WO2003100429A2 (en) * | 2002-05-23 | 2003-12-04 | Sunnybrook And Women's College Health Sciences Centre | Diagnosis of hepatocellular carcinoma |
Non-Patent Citations (6)
Title |
---|
DATABASE EMBL [online] 11 April 2002 (2002-04-11), XP002333985, retrieved from EMBL Database accession no. ACA54656, 05-JUN-2003 * |
DATABASE EMBL [online] 20 January 2003 (2003-01-20), XP002333983, retrieved from EMBL Database accession no. ABZ11419, 20-JAN-2003 * |
DATABASE EMBL [online] 23 January 2002 (2002-01-23), XP002333984, retrieved from EMBL Database accession no. ABA11768, 23-JAN-2002 * |
MIYASAKA Y ET AL: "ANALYSIS OF DIFFERENTIALLY EXPRESSED GENES IN HUMAN HEPATOCELLULAR CARCINOMA USING SUPPRESSION SUBTRACTIVE HYBRIDIZATION", BRITISH JOURNAL OF CANCER, LONDON, GB, vol. 85, no. 2, July 2001 (2001-07-01), pages 228 - 234, XP008013867, ISSN: 0007-0920 * |
XIAO Q ET AL: "DUTP PYROPHOSPHATASE AND URACIL-DNA GLYCOSYLASE IN RAT LIVER AND HEPATOMAS", INTERNATIONAL JOURNAL OF BIOCHEMISTRY, TARRYTOWN, NY, US, vol. 24, no. 3, 1992, pages 437 - 445, XP002291123 * |
XU X-R ET AL: "Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 98, no. 26, 18 December 2001 (2001-12-18), pages 15089 - 15094, XP002231180, ISSN: 0027-8424 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US8296076B2 (en) | 2008-09-20 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuoploidy by sequencing |
US8682594B2 (en) | 2008-09-20 | 2014-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9353414B2 (en) | 2008-09-20 | 2016-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9404157B2 (en) | 2008-09-20 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
Also Published As
Publication number | Publication date |
---|---|
WO2005085861A2 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005085861A3 (en) | Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer | |
WO2002080754A3 (en) | Methods for using annexin for detecting cell death in vivo and treating associated conditions | |
WO2004061423A3 (en) | Compositions and methods for diagnosing and treating colon cancers | |
WO2004050707A3 (en) | Tumor-specific recognition molecules | |
WO2003101401A3 (en) | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer | |
WO2006113483A3 (en) | Methods and compositions for treating or preventing cancer | |
WO2007053573A3 (en) | Treatment of cancer with sorafenib | |
WO2006015079A3 (en) | Erm family binding agents and their use in diagnosis and treatment of proliferative conditions | |
WO2008077077A3 (en) | Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors | |
WO2009009173A3 (en) | Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases | |
WO2006091459A3 (en) | Compositions and methods for treating vascular permeability | |
WO2007033167A3 (en) | Compositions and methods for detecting and treating cancer | |
WO2004050026A3 (en) | Compositions and methods for treating prostate cancer | |
WO2006102504A3 (en) | Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors | |
WO2004070062A3 (en) | Compositions and methods for diagnosing and treating cancers | |
WO2004112829A3 (en) | Compositions and methods for the diagnosis and treatment of tumors of glial origin | |
WO2004093803A3 (en) | Photochemotherapeutic compounds for use in treatment of pin1-associated states | |
WO2007149481A3 (en) | Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment | |
WO2007149287A3 (en) | Transfer factor compositions and methods | |
WO2005030144A3 (en) | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | |
WO2007117657A3 (en) | Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency | |
WO2005085188A3 (en) | Compounds and methods for anti-tumor therapy | |
AU2003300368A8 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
WO2004029287A3 (en) | Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer | |
WO2006034328A3 (en) | Wnt proteins and detection and treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |